ANTIMICROBIAL SENSITIVITY OF GRAM-NEGATIVE BACTERIA WITH BETA LACTAM /BETA LACTAMASE INHIBITOR COMBINATION OF DRUGS IN COMPARISON TO OTHER ANTIBIOTICS IN TERTIARY CARE CENTER.

Sood S. Comparative evaluation of the in-vitro activity of six β-lactam/β-lactamase inhibitor combinations against Gram Negative Bacilli. J Clin Diagn Res 2013;7(2):224-8.  

Chapman TM, Perry CM.  Cefepime: a review of its use in the management of hospitalized patients with pneumonia. Am J Respir Med 2003;2(1):75-107.

Yang Y, Rasmussen BA, Shlaes DM. Class A beta-lactamases—enzyme-inhibitor interactions and resistance. Pharmacol Ther 1999;83(2):141-51.              

Endimiani A, Perez F, Bonomo RA. Cefepime: a reappraisal in an era of increasing antimicrobial resistance. Expert Rev Anti Infect Ther 2008;6(6):805-24.           

Sharma S, Gupta A, Arora A. Cefepime Tazobactam: a new β lactam/ β lactamase inhibitor combination against ESBL producing gram negative bacilli. Int J Pharm Biomed Sci 2012;3(2):35-8.

Nguyen HM, Shier KL, Graber CJ. Determining a clinical framework for use of cefepime and beta-lactam/beta-lactamase inhibitors in the treatment of infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae. J Antimicrob Chemother 2014;69(4):871-80.                        

Winn W. Konemann’s Color atlas and diagnostic text of microbiology. 6th edn. Philadelphia, PA: Lippincott Williams & Wilkins Publishers 2006: p. 945-1021.

Kirby WM, Yoshihara GM, Sundsted KS, et al. Clinical usefulness of a single disc method for antibiotic sensitivity testing. Antibiotics Annu 1956-1957;892-7.       

EUCAST 2016. Breakpoint tables for interpretation of MICs and zone diameters. Version 6.0, January 2016. http://www.eucast.org/clinical_breakpoints/.

Bhat YR, Lewis LE, Vandana KE. Bacterial isolates of early-onset neonatal sepsis and their antibiotic susceptibility pattern between 1998 and 2004: an audit from a center in India. Ital J Pediatr 2011;37:32.            

Shrestha S, Shrestha NC, Singh DS, et al. Bacterial isolates and its antibiotic susceptibility pattern in NICU. Kathmandu Univ Med J 2013;11(41):66-70.

Veeraraghavan B, Jesudason MR, Prakasah JAJ, et al. Antimicrobial susceptibility profiles of gram-negative bacteria causing infections collected across India during 2014–2016: study for monitoring antimicrobial resistance trend report. Indian J Med Microbiol 2018;36(1):32-6.

Abdul KG, Vidyalakshmi PR, Jayalakshmi VA, et al. Susceptibility profile of Gram-negative bacteremic isolates to beta lactam-beta lactamase inhibitor agents in comparison to other antibiotics. Indian J Cancer 2014;51(4):450-2.             

Navaneethakrishnan RM, Sundaram M, Ismail M. Susceptibility of bacterial isolates to combination of third generation cephalosporins and sulbactams. J Evolution Med Dent Sci 2016;5(37):2173-7.                        

Bhat V, Gupta S, Kelkar R, et al. Bacteriological profile and antibiotic susceptibility patterns of clinical isolates in a tertiary care cancer center. Indian J Med Paediatr Oncol 2016;37(1):20-4.                   

Dalal P, Gathwala G, Gupta M, et al. Bacteriological profile and antimicrobial sensitivity pattern in neonatal sepsis: a study from North India. Int J Res Med Sci 2017;5(4):1541-5.